CVS Health Stock-Based Compensation 2010-2025 | CVS

CVS Health stock-based compensation for the twelve months ending March 31, 2025 was $1.339B, a 10.31% decline year-over-year.

  • CVS Health annual stock-based compensation for 2024 was $0.54B, a 8.16% decline from 2023.
  • CVS Health annual stock-based compensation for 2023 was $0.588B, a 31.54% increase from 2022.
  • CVS Health annual stock-based compensation for 2022 was $0.447B, a 7.64% decline from 2021.

CVS Health Stock-Based Compensation 2010-2025 | CVS

  • CVS Health annual stock-based compensation for 2024 was $0.54B, a 8.16% decline from 2023.
  • CVS Health annual stock-based compensation for 2023 was $0.588B, a 31.54% increase from 2022.
  • CVS Health annual stock-based compensation for 2022 was $0.447B, a 7.64% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$145.3B
Elevance Health (ELV)$64.4B
Cencora (COR)$55.5B
DiDi Global (DIDIY)$26B
Labcorp Holdings (LH)$21.9B
Natera (NTRA)$18.8B
BioMerieux (BMXMF)$17.1B
ICON (ICLR)$15.3B
EUROFINS SCIENT (ERFSF)$14.9B
CochLear (CHEOY)$13.4B
Solventum (SOLV)$12.8B
Medpace Holdings (MEDP)$12.7B
Revvity (RVTY)$11.2B
Viatris (VTRS)$10.9B
Avantor (AVTR)$9.5B
Sonic Healthcare (SKHHY)$9.2B
Charles River Laboratories (CRL)$8.8B
HealthEquity (HQY)$8.3B
Caris Life Sciences,�Inc (CAI)$6.9B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5.1B
BrightSpring Health Services (BTSG)$3.6B
Sotera Health (SHC)$3.5B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.6B
Concentras Parent (CON)$2.6B
GeneDx Holdings (WGS)$2.4B
Alignment Healthcare (ALHC)$2.3B
Progyny (PGNY)$2B
PACS (PACS)$1.8B